Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Cardiovascular diseases

Study results do not support widespread use of statins in old and very old populations

Study suggests that statin use is ineffective for primary prevention of cardiovascular disease in older people without diabetes.

elderly woman taking a statin pill

Source: Alamy

The study results did not support the widespread use of statins in old and very old populations, but they did support treatment in those with type 2 diabetes younger than 85 years

Statins do not prevent the development of atherosclerotic cardiovascular disease (CVD) in people without diabetes aged 75 years and over, according to a study published in the BMJ (online, 5 September 2018)[1]

Researchers used primary care data on 46,864 people in Catalonia, Spain, with no history of atherosclerotic CVD split into two age groups: those aged 75–84 years and those aged 85 years and older. Participants were stratified by presence of type 2 diabetes and as statin non-users or new users.

Over a median follow-up of 5.6 years, there was no significant difference in the risk of atherosclerotic CVD or all-cause mortality between those who received statins and those who did not in either age group.

However, in the younger age group, those with diabetes had a 24% reduced risk of atherosclerotic CVD and a 16% reduced risk of death when they took statins. But this effect was substantially reduced after the age of 85 years and disappeared in those aged 90 years and over.

The researchers explained that while the effectiveness of statins in the secondary prevention of cardiovascular events was well established in those aged 75 years and over, there was less evidence to inform primary prevention.

“These results do not support the widespread use of statins in old and very old populations, but they do support treatment in those with type 2 diabetes younger than 85 years,” the team concluded.

Citation: Clinical Pharmacist DOI: 10.1211/CP.2018.20205531

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • elderly woman taking a statin pill

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.